Maze Therapeutics, Inc. · NASDAQ:MAZE
Deep Track Capital, LP reported a 9.02% stake in Maze Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Deep Track Capital, LP reported a 9.02% stake in Maze Therapeutics, Inc., 3,948,910 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 9.02%
- Shares
- 3,948,910
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 9.02% | 3,948,910 |
| Deep Track Biotechnology Master Fund, Ltd. | 9.02% | 3,948,910 |
| David Kroin | 9.02% | 3,948,910 |
Source
Related
- Maze Therapeutics, Inc.
- Deep Track Capital, LP
- Maze Therapeutics, Inc. shareholders
- Schedule 13G · Deep Track Capital, LP · Feb 7, 2025
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026